Alcoholic liver disease
暂无分享,去创建一个
[1] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[2] S. Leucht,et al. Opioid antagonists for alcohol dependence. , 2010, The Cochrane database of systematic reviews.
[3] P. Christoffersen,et al. Histological changes in human liver biopsies from chronic alcoholics. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[4] G. Gores,et al. A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. , 2008, Gastroenterology.
[5] S. Pol,et al. Influence of liver biopsy on abstinence in alcohol-dependent patients. , 2008, Alcohol and alcoholism.
[6] H. Saconato,et al. Systematic review: glucocorticosteroids for alcoholic hepatitis – a Cochrane Hepato‐Biliary Group systematic review with meta‐analyses and trial sequential analyses of randomized clinical trials , 2008, Alimentary pharmacology & therapeutics.
[7] P. Deltenre,et al. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. , 2008, Journal of hepatology.
[8] Julian P T Higgins,et al. Recent developments in meta‐analysis , 2008, Statistics in medicine.
[9] G. Gasbarrini,et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study , 2007, The Lancet.
[10] Y. Israel,et al. Assessment of Prognostic Factors in Alcoholic Liver Disease: Toward a Global Quantitative Expression of Severity , 2007, Hepatology.
[11] B. Wolff,et al. MARS dialysis in decompensated alcoholic liver disease: A single‐center experience , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[12] Alexandre Louvet,et al. The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids , 2007, Hepatology.
[13] C. Ripoll,et al. Prognostic value of hepatic venous pressure gradient for in‐hospital mortality of patients with severe acute alcoholic hepatitis , 2007, Alimentary pharmacology & therapeutics.
[14] F. Wurst,et al. BIOMARKER: Phosphatidylethanol as a sensitive and specific biomarker—comparison with gamma‐glutamyl transpeptidase, mean corpuscular volume and carbohydrate‐deficient transferrin , 2007, Addiction biology.
[15] D. Kivlahan,et al. Alcohol screening scores and risk of hospitalizations for GI conditions in men. , 2007, Alcoholism, clinical and experimental research.
[16] O. Niemelä. Biomarkers in alcoholism. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[17] Roger Williams,et al. Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis , 2007, Hepatology.
[18] J. O'grady,et al. Liver transplantation alcohol related liver disease: (deliberately) stirring a hornet’s nest! , 2006, Gut.
[19] F. Tagliaro,et al. Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[20] J. Brick,et al. Standardization of alcohol calculations in research. , 2006, Alcoholism, clinical and experimental research.
[21] A. Soultati,et al. Predicting utility of a model for end stage liver disease in alcoholic liver disease. , 2006, World journal of gastroenterology.
[22] David Couper,et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. , 2006, JAMA.
[23] B. Portmann,et al. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. , 2006, Journal of hepatology.
[24] A. McCullough,et al. Steroids or cocktails for alcoholic hepatitis. , 2006, Journal of hepatology.
[25] M. Plauth,et al. ESPEN Guidelines on Enteral Nutrition: Liver disease. , 2006, Clinical nutrition.
[26] S. Jaber,et al. Are preoperative patterns of alcohol consumption predictive of relapse after liver transplantation for alcoholic liver disease? , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[27] M. Aalto,et al. Use of laboratory markers and the audit questionnaire by primary care physicians to detect alcohol abuse by patients. , 2005, Alcohol and alcoholism.
[28] P. Mathurin. Is alcoholic hepatitis an indication for transplantation? Current management and outcomes , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[29] C. Gluud,et al. Milk Thistle for Alcoholic and/or Hepatitis B or C Liver Diseases—A Systematic Cochrane Hepato-Biliary Group Review with Meta-Analyses of Randomized Clinical Trials , 2005, The American Journal of Gastroenterology.
[30] Neil Skolnik,et al. Helping Patients Who Drink Too Much , 2005 .
[31] M. Soyka,et al. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. , 2005, Addiction.
[32] G. Friedman,et al. Alcohol drinking and risk of hospitalization for heart failure with and without associated coronary artery disease. , 2005, The American journal of cardiology.
[33] P. Hayes,et al. Alcoholic hepatitis: from pathogenesis to treatment , 2005, Current medical research and opinion.
[34] L S Murray,et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score , 2005, Gut.
[35] C. De Simone,et al. Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases , 2005, Journal of clinical gastroenterology.
[36] Paul L Doering,et al. Acamprosate for the treatment of alcohol dependence. , 2005, Clinical therapeutics.
[37] P. Burra,et al. Liver transplantation in alcoholic patients , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[38] B. Runyon,et al. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. , 2005, Journal of hepatology.
[39] C. Gluud,et al. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis. , 2005, The Cochrane database of systematic reviews.
[40] M. Pedrosa,et al. Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival. , 2005, Gastroenterology.
[41] K. Punnonen,et al. Biomarkers of alcohol consumption in patients classified according to the degree of liver disease severity , 2005, Scandinavian journal of clinical and laboratory investigation.
[42] E. D’Amico,et al. Identification of and Guidance for Problem Drinking by General Medical Providers: Results From a National Survey , 2005, Medical care.
[43] F. Wurst,et al. Emerging biomarkers: new directions and clinical applications. , 2005, Alcoholism, clinical and experimental research.
[44] W. Kim,et al. MELD accurately predicts mortality in patients with alcoholic hepatitis , 2005, Hepatology.
[45] C. M. Leevy,et al. Nutritional aspects of alcoholic liver disease. , 2005, Clinics in liver disease.
[46] M. Tosti,et al. Correlation of alcohol consumption with liver histological features in non-cirrhotic patients , 2005, European journal of gastroenterology & hepatology.
[47] E. Cabré,et al. Combining steroids with enteral nutrition: a better therapeutic strategy for severe alcoholic hepatitis? Results of a pilot study , 2004, European journal of gastroenterology & hepatology.
[48] Gurvaneet Randhawa,et al. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse. , 2004, American family physician.
[49] C. Duvoux,et al. Predictive factors of alcohol relapse after orthotopic liver transplantation for alcoholic liver disease. , 2004, Gastroenterologie clinique et biologique.
[50] Jin-yan Luo,et al. Risk factors for alcoholic liver disease in China. , 2004, World journal of gastroenterology.
[51] J. Levitsky,et al. Diagnosis and therapy of alcoholic liver disease. , 2004, Seminars in liver disease.
[52] J. Tolstrup,et al. Alcohol and cirrhosis: dose--response or threshold effect? , 2004, Journal of hepatology.
[53] J. Balldin,et al. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. , 2004, Alcohol and alcoholism.
[54] U. John,et al. Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the Study of Health in Pomerania (SHIP). , 2004, Alcoholism, clinical and experimental research.
[55] Adnan Said,et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. , 2004, Journal of hepatology.
[56] P. Broët,et al. A double‐blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis , 2004, Hepatology.
[57] T. Wright,et al. Risks of a range of alcohol intake on hepatitis C‐related fibrosis , 2004, Hepatology.
[58] G. Gores,et al. A Pilot Study of the Safety and Tolerability of Etanercept in Patients with Alcoholic Hepatitis , 2004, American Journal of Gastroenterology.
[59] C. Lieber. New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments , 2004, Current gastroenterology reports.
[60] Y. Mahida,et al. A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis , 2004, Alimentary pharmacology & therapeutics.
[61] D. Valla,et al. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone , 2003, Hepatology.
[62] J. Whitfield,et al. Combining carbohydrate-deficient transferrin and gamma-glutamyltransferase to increase diagnostic accuracy for problem drinking. , 2003, Alcohol and alcoholism.
[63] Aniruddha M. Deshpande,et al. Standardized Reporting of Clinical Practice Guidelines: A Proposal from the Conference on Guideline Standardization , 2003, Annals of Internal Medicine.
[64] T. Tran,et al. The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis , 2003, American Journal of Gastroenterology.
[65] T. Ide,et al. Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report. , 2003, Alcoholism, clinical and experimental research.
[66] D. Arveiler,et al. Joint use of clinical parameters, biological markers and CAGE questionnaire for the identification of heavy drinkers in a large population-based sample. , 2003, Alcohol and alcoholism.
[67] D. Valla,et al. Five‐year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence , 2003, Liver international : official journal of the International Association for the Study of the Liver.
[68] A. Moser,et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease , 2003, Hepatology.
[69] C. Lieber. Hepatitis C and alcohol. , 2003, Journal of clinical gastroenterology.
[70] Majid Ezzati,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[71] P. Perney,et al. Wine consumption is not associated with a decreased risk of alcoholic cirrhosis in heavy drinkers. , 2002, Alcohol and alcoholism.
[72] C. Lieber. S-adenosyl-L-methionine: its role in the treatment of liver disorders. , 2002, The American journal of clinical nutrition.
[73] F. Corrales,et al. Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury. , 2002, The American journal of clinical nutrition.
[74] A. Rougemont,et al. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. , 2002, Journal of hepatology.
[75] Katsuyoshi Ito,et al. Cirrhosis: A Modified Caudate-to-Right-Lobe Ratio , 2001 .
[76] C. Eriksson,et al. Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence. , 2002, Alcoholism, clinical and experimental research.
[77] T. Reynolds,et al. Duplex Doppler Ultrasound of the Hepatic Artery in Patients With Acute Alcoholic Hepatitis , 2002, Journal of clinical gastroenterology.
[78] T. Sørensen,et al. Lower risk for alcohol‐induced cirrhosis in wine drinkers , 2002, Hepatology.
[79] R. Carithers,et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. , 2002, Journal of hepatology.
[80] John B Saunders,et al. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. , 2002, Alcoholism, clinical and experimental research.
[81] M. Riggs,et al. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis , 2002, BMC gastroenterology.
[82] D. Altman,et al. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice , 2002, Journal of health services research & policy.
[83] Edward A. Graviss,et al. A systematic review of the diagnostic accuracy of physical examination for the detection of cirrhosis , 2001, BMC Medical Informatics Decis. Mak..
[84] T. J. Peters,et al. Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis , 2001, European journal of neurology.
[85] P. Sharpe,et al. Biochemical detection and monitoring of alcohol abuse and abstinence , 2001, Annals of clinical biochemistry.
[86] G. Gores,et al. Pathogenesis, diagnosis, and treatment of alcoholic liver disease. , 2001, Mayo Clinic proceedings.
[87] T. Starzl,et al. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. , 2001, Transplantation.
[88] V. Vilgrain. Ultrasound of diffuse liver disease and portal hypertension , 2001, European Radiology.
[89] B. Grant,et al. The critical dimension of ethnicity in liver cirrhosis mortality statistics. , 2001, Alcoholism, clinical and experimental research.
[90] Marie-Cecile O. Tidwell,et al. Alcohol and gambling pathology among U.S. adults: prevalence, demographic patterns and comorbidity. , 2001, Journal of studies on alcohol.
[91] K. Ikejima,et al. Sex difference in alcohol-related organ injury. , 2001, Alcoholism, clinical and experimental research.
[92] J. Neuberger,et al. Orthotopic liver transplantation for alcoholic liver disease: A retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[93] M. Giacca,et al. Genetic Determinants of Ethanol-Induced Liver Damage , 2001, Molecular medicine.
[94] G Pozzato,et al. Gender differences in pharmacokinetics of alcohol. , 2001, Alcoholism, clinical and experimental research.
[95] A. Mihas,et al. Nutritional therapy for alcoholic hepatitis: new life for an old idea. , 2001, Gastroenterology.
[96] W. Miller,et al. How effective is alcoholism treatment in the United States? , 2001, Journal of studies on alcohol.
[97] C. Day. Apoptosis in alcoholic hepatitis: a novel therapeutic target? , 2001, Journal of hepatology.
[98] M. Ramstedt. Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries. , 2001, Addiction.
[99] T M Therneau,et al. A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.
[100] L. Seeff,et al. The Relationship of Acute Transfusion-Associated Hepatitis to the Development of Cirrhosis in the Presence of Alcohol Abuse , 2001, Annals of Internal Medicine.
[101] T. Reynolds,et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.
[102] H. Okazaki,et al. Discrimination of alcoholic from virus-induced cirrhosis on MR imaging. , 2000, AJR. American journal of roentgenology.
[103] C. Day. Who Gets Alcoholic Liver Disease: Nature or Nurture? , 2000, Journal of the Royal College of Physicians of London.
[104] E. Vartiainen,et al. Dose response of laboratory markers to alcohol consumption in a general population. , 2000, American journal of epidemiology.
[105] S. Kihara,et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.
[106] A. Palmer,et al. The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate. , 2000, Alcohol and alcoholism.
[107] R. Schwan,et al. Objective diagnosis of alcohol abuse: compared values of carbohydrate-deficient transferrin (CDT), gamma-glutamyl transferase (GGT), and mean corpuscular volume (MCV). , 2000, Alcoholism, clinical and experimental research.
[108] L. Yanek,et al. Detecting symptoms of alcohol abuse in primary care settings. , 2000, Archives of family medicine.
[109] P. O'Connor,et al. Screening for alcohol problems in primary care: a systematic review. , 2000, Archives of internal medicine.
[110] L. Midanik,et al. The effect of screening on prevalence estimates of alcohol dependence and social consequences. , 2000, Journal of studies on alcohol.
[111] E. Cabré,et al. Short‐ and long‐term outcome of severe alcohol‐induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial , 2000, Hepatology.
[112] P. Bedossa,et al. Appropriateness of liver biopsy. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[113] A. Neskovic,et al. Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. , 2000, Journal of the American College of Cardiology.
[114] T. Kuroki,et al. Contribution of hepatitis C virus to the progression of alcoholic liver disease. , 2000, Alcoholism, clinical and experimental research.
[115] C. Bodian,et al. Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation. , 2000, Transplantation.
[116] D. Crabb,et al. Pathogenesis of alcoholic liver disease: newer mechanisms of injury. , 1999, The Keio journal of medicine.
[117] S. Newton,et al. Recidivism and return to work posttransplant. Recipients with substance abuse histories. , 1999, Journal of substance abuse treatment.
[118] M. Plauth,et al. Liver cirrhosis: rationale and modalities for nutritional support--the European Society of Parenteral and Enteral Nutrition consensus and beyond. , 1999, Current opinion in clinical nutrition and metabolic care.
[119] J. Rodés,et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. , 1999, Journal of hepatology.
[120] A. McCullough,et al. Treatment of alcoholic hepatitis. , 1998, Clinics in liver disease.
[121] K. Mullen,et al. POTENTIAL NEW THERAPIES FOR ALCOHOLIC LIVER DISEASE , 1998 .
[122] R. Wiesner,et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. , 1998, Transplantation.
[123] E. Mezey. Dietary fat and alcoholic liver disease , 1998, Hepatology.
[124] S. Cantor,et al. Ethnic and Sex Bias in Primary Care Screening Tests for Alcohol Use Disorders , 1998, Annals of Internal Medicine.
[125] D. V. van Thiel,et al. Liver transplantation for alcoholic liver disease. , 1998, Hepato-gastroenterology.
[126] G. Brandi,et al. Drinking habits as cofactors of risk for alcohol induced liver damage , 1997, Gut.
[127] Gordon S. Smith,et al. The accuracy of the CAGE, the Brief Michigan Alcoholism Screening Test, and the Alcohol Use Disorders Identification Test in screening trauma center patients for alcoholism. , 1997, The Journal of trauma.
[128] R. Caetano,et al. DSM-IV alcohol dependence and drinking in the U.S. population: a risk analysis. , 1997, Annals of epidemiology.
[129] G. Corrao,et al. Are the recent trends in liver cirrhosis mortality affected by the changes in alcohol consumption? Analysis of latency period in European countries. , 1997, Journal of studies on alcohol.
[130] B. Grant. Barriers to alcoholism treatment: reasons for not seeking treatment in a general population sample. , 1997, Journal of studies on alcohol.
[131] R. Groszmann,et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. , 1997, Gastroenterology.
[132] F. Capron,et al. Excess weight risk factor for alcoholic liver disease , 1997, Hepatology.
[133] T. Reed,et al. Genetic predisposition to organ-specific endpoints of alcoholism. , 1996, Alcoholism, clinical and experimental research.
[134] D MacKenzie,et al. Identifying hazardous or harmful alcohol use in medical admissions: a comparison of audit, cage and brief mast. , 1996, Alcohol and alcoholism.
[135] B Carstensen,et al. Accuracy of clinical diagnosis of cirrhosis among alcohol-abusing men. , 1996, Journal of clinical epidemiology.
[136] C. Degott,et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. , 1996, Gastroenterology.
[137] T. Sørensen,et al. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study , 1996, Hepatology.
[138] C. Erickson,et al. Conference summary: Consensus Conference on Alcohol Dependence and the Role of Pharmacotherapy in its Treatment. , 1996, Alcoholism, clinical and experimental research.
[139] M. Perola,et al. Early perivenular fibrogenesis--precirrhotic lesions among moderate alcohol consumers and chronic alcoholics. , 1995, Journal of hepatology.
[140] M. Bennett,et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver , 1995, The Lancet.
[141] G. van Melle,et al. Screening for excessive alcohol drinking. Comparative value of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume. , 1995, Archives of internal medicine.
[142] S. Wickramasinghe,et al. Ethnic differences in the biological consequences of alcohol abuse: a comparison between south Asian and European males. , 1995, Alcohol and alcoholism.
[143] E. Christensen,et al. Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. , 1995, Gut.
[144] S. Shapiro,et al. Alcohol consumption and the risk of major upper gastrointestinal bleeding. , 1995, The American journal of gastroenterology.
[145] Thomas E. Moritz,et al. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. , 1995, Alcoholism, clinical and experimental research.
[146] J. Kitchens,et al. Does this patient have an alcohol problem? , 1994, JAMA.
[147] E. Villanueva,et al. Comparison of the CAGE questionnaire versus some biochemical markers in the diagnosis of alcoholism. , 1994, Alcohol and alcoholism.
[148] H. Bonkovsky,et al. Nutritional supplementation in chronic liver disease: An analytical review , 1994, Hepatology.
[149] A. Paton,et al. The risk of alcohol. , 1993, Addiction.
[150] G. Bird. Investigation of alcoholic liver disease. , 1993, Bailliere's clinical gastroenterology.
[151] J. Nicolás,et al. Relationship between ethanol-related diseases and nutritional status in chronically alcoholic men. , 1993, Alcohol and alcoholism.
[152] A. Penttilä,et al. Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. , 1993, Alcoholism, clinical and experimental research.
[153] J B Saunders,et al. Epidemiology of alcoholic liver disease. , 1993, Bailliere's clinical gastroenterology.
[154] O. Aasland,et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. , 1993, Addiction.
[155] D. Bunout,et al. Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. , 1993, JPEN. Journal of parenteral and enteral nutrition.
[156] H. Prytz,et al. Identification of alcoholic liver disease or hidden alcohol abuse in patients with elevated liver enzymes , 1993, Journal of internal medicine.
[157] C. Day,et al. Genetic predisposition to alcoholic liver disease. , 1992, Gut.
[158] J M Scheller,et al. The rational clinical examination. , 1992, JAMA.
[159] K. Brown. Alcohol hepatotoxicity: a genotypic predisposition? , 1992, The American journal of gastroenterology.
[160] J. Benhamou,et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. , 1992, The New England journal of medicine.
[161] E. Mezey. Interaction Between Alcohol and Nutrition in the Pathogenesis of Alcoholic Liver Disease , 1991, Seminars in liver disease.
[162] G. S. Smith,et al. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. , 1991, The American journal of gastroenterology.
[163] R. Moore,et al. Alcohol abuse: comparison of two methods for assessing its prevalence and associated morbidity in hospitalized patients. , 1991, The American journal of medicine.
[164] K. Ishak,et al. Alcoholic liver disease: pathologic, pathogenetic and clinical aspects. , 1991, Alcoholism, clinical and experimental research.
[165] P. Gartside,et al. Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. , 1991, The American journal of gastroenterology.
[166] C. Turner,et al. How much alcohol is in a 'standard drink'? An analysis of 125 studies. , 1990, British journal of addiction.
[167] T. Imperiale,et al. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. , 1990, Annals of internal medicine.
[168] G. Marchesini,et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. , 1990, Journal of hepatology.
[169] G. Marchesini,et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: A randomized double-blind casein-controlled trial☆ , 1990 .
[170] C. Lieber,et al. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. , 1990, The New England journal of medicine.
[171] M. Zillikens,et al. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. , 1989, BMJ.
[172] B. Schneider,et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. , 1989, Journal of hepatology.
[173] R. Carithers,et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. , 1989, Annals of internal medicine.
[174] G. Geller,et al. Prevalence, detection, and treatment of alcoholism in hospitalized patients. , 1989, JAMA.
[175] K. Ishak,et al. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. , 1988, Gastroenterology.
[176] Y. Israel,et al. LONG-TERM TREATMENT OF ALCOHOLIC LIVER DISEASE WITH PROPYLTHIOURACIL , 1988, The Lancet.
[177] D. Bunout,et al. Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics. , 1988, The American journal of clinical nutrition.
[178] H. Michel,et al. [Treatment of acute alcoholic hepatitis with prednisolone. 45 patients]. , 1987, Presse medicale.
[179] B. Ducot,et al. Interobserver agreement in the physical diagnosis of alcoholic liver disease , 1987, Digestive Diseases and Sciences.
[180] M. Eckardt,et al. Biological correlates and detection of alcohol abuse and alcoholism , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[181] R. N. Macsween,et al. Histologic Spectrum of Alcoholic Liver Disease , 1986, Seminars in liver disease.
[182] B. Lacour,et al. Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: Diagnostic value and interpretation in a liver unit , 1986, Hepatology.
[183] T. Tosch,et al. Significance of megamitochondria in alcoholic liver disease. , 1986, Gastroenterology.
[184] J. Pignon,et al. Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patients , 1985, Hepatology.
[185] C. Lieber,et al. Perivenular fibrosis as precursor lesion of cirrhosis. , 1985, JAMA.
[186] A. Lonardo,et al. [Variability of the clinical and laboratory aspects in the presentation of chronic liver diseases in relation to their etiology. Analysis of a case study and review of the literature]. , 1985, Minerva medica.
[187] L. Seeff,et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. , 1984, The New England journal of medicine.
[188] J. Ewing,et al. Detecting alcoholism. The CAGE questionnaire. , 1984, JAMA.
[189] ThorkildI. A. Sørensen,et al. PROSPECTIVE EVALUATION OF ALCOHOL ABUSE AND ALCOHOLIC LIVER INJURY IN MEN AS PREDICTORS OF DEVELOPMENT OF CIRRHOSIS , 1984, The Lancet.
[190] T. Poynard,et al. Prognostic Value of Total Serum Bilirubin/γ‐Glutamyl Transpeptidase Ratio in Cirrhotic Patients , 1984, Hepatology.
[191] C. Mendenhall,et al. Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. , 1984, The American journal of medicine.
[192] L. Midanik. The validity of self-reported alcohol consumption and alcohol problems: a literature review. , 1982, British journal of addiction.
[193] H A Skinner,et al. Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. , 1982, Journal of studies on alcohol.
[194] C. Lieber,et al. Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. , 1982, Gastroenterology.
[195] I. Maltzman,et al. Controlled drinking by alcoholics? New findings and a reevaluation of a major affirmative study. , 1982, Science.
[196] A. Eddleston,et al. Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. , 1982, Gut.
[197] J. Saunders,et al. Do women develop alcoholic liver disease more readily than men? , 1981, British medical journal.
[198] Jerold A. Cohen,et al. The SGOT/SGPT ratio—An indicator of alcoholic liver disease , 1979, Digestive Diseases and Sciences.
[199] D. Kershenobich,et al. Treatment of cirrhosis with colchicine. A double-blind randomized trial. , 1979, Gastroenterology.
[200] J. E. Hardison,et al. The importance of a coexistent hepatic rub and bruit. A clue to the diagnosis of cancer in the liver. , 1979, JAMA.
[201] J. Boyer,et al. Nonalcoholic liver disease: Overlooked causes of liver injury in patients with heavy alcohol consumption , 1979 .
[202] M. Uribe,et al. Oral prednisone for chronic active liver disease: dose responses and bioavailability studies. , 1978, Gut.
[203] Willis C. Maddrey,et al. Corticosteroid therapy of alcoholic hepatitis. , 1978, Gastroenterology.
[204] F. Iber,et al. A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients. , 1978, The American journal of gastroenterology.
[205] H. Fallon,et al. Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. , 1978, Gastroenterology.
[206] S. Sherlock,et al. Studies in alcoholic liver disease in Britain , 1974, Gut.
[207] R. N. Macsween,et al. Hepatic cirrhosis: A clinico-pathological review of 520 cases , 1973, Journal of clinical pathology.
[208] T. Reynolds,et al. Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial. , 1973 .
[209] D. W. Goodwin,et al. Alcohol problems in adoptees raised apart from alcoholic biological parents. , 1973, Archives of general psychiatry.
[210] J. Galambos. Natural history of alcoholic hepatitis. 3. Histological changes. , 1972, Gastroenterology.
[211] J. Galambos,et al. Natural history of alcoholic hepatitis. II. The long-term prognosis. , 1971, The American journal of gastroenterology.
[212] C. Pope,et al. Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial. , 1971, The New England journal of medicine.
[213] J. Galambos,et al. Natural history of alcoholic hepatitis , 1971, The American Journal of Digestive Diseases.
[214] S. Zoneraich,et al. Diagnostic Significance of Abdominal Arterial Murmurs in Liver and Pancreatic Disease , 1971, Angiology.
[215] H. Fallon,et al. Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. , 1971, Annals of internal medicine.
[216] C. H. Patrick. Alcohol, Culture, and Society, , 1970 .
[217] L. Goldstein. Enlarged, tortuous arteries and hepatic bruit. , 1968, JAMA.
[218] C. Mendenhall. Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis , 1968, The American Journal of Digestive Diseases.
[219] W. J. Powell,et al. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. , 1968, The American journal of medicine.
[220] C. Lieber,et al. EFFECTS OF PROLONGED ETHANOL INTAKE: PRODUCTION OF FATTY LIVER DESPITE ADEQUATE DIETS. , 1965, The Journal of clinical investigation.
[221] C. M. Leevy. FATTY LIVER: A STUDY OF 270 PATIENTS WITH BIOPSY PROVEN FATTY LIVER AND A REVIEW OF THE LITERATURE , 1962 .
[222] THE WORLD HEALTH ORGANIZATION , 1954 .
[223] R. Brůha,et al. Alcoholic liver disease. , 2012, World journal of hepatology.
[224] M. Savolainen,et al. Biochemical markers of alcoholism , 2007, Clinical chemistry and laboratory medicine.
[225] T. Umemura,et al. Severe alcoholic hepatitis with extremely high neutrophil count successfully treated by granulocytapheresis. , 2006, Internal medicine.
[226] The Role of Biomarkers in the Treatment of Alcohol Use Disorders, 2012 Revision , 2006 .
[227] A. Rambaldi,et al. S-adenosyl-L-methionine for alcoholic liver diseases. , 2006, The Cochrane database of systematic reviews.
[228] R. Schwabe,et al. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[229] F. W. Hoffbauer. Liver disease , 2005, The American Journal of Digestive Diseases.
[230] M. Uribe,et al. Alcoholic liver disease. An update. , 2005, Annals of hepatology.
[231] F. Gudé,et al. Liver disease in heavy drinkers with and without alcohol withdrawal syndrome. , 2004, Alcoholism, clinical and experimental research.
[232] F. Buntinx,et al. The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis. , 2004, Journal of clinical epidemiology.
[233] D. Crabb,et al. Recent Advances in Alcoholic Liver Disease , 2004 .
[234] Roger Williams,et al. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. , 2003, Journal of hepatology.
[235] P. Brissot,et al. Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. , 2002, Journal of hepatology.
[236] S. Stewart. Racial and ethnic differences in alcohol-associated aspartate aminotransferase and gamma-glutamyltransferase elevation. , 2002, Archives of internal medicine.
[237] C. Gluud,et al. Propylthiouracil for alcoholic liver disease. , 2002, The Cochrane database of systematic reviews.
[238] L. Midanik,et al. A 10-year national trend study of alcohol consumption, 1984-1995: is the period of declining drinking over? , 2000, American journal of public health.
[239] B. Grant,et al. Withdrawal and tolerance: prognostic significance in DSM-IV alcohol dependence. , 2000, Journal of studies on alcohol.
[240] J. Eisenberg. Agency for Health Care Policy and Research. , 1999, Medical care.
[241] H Wechsler,et al. Binge drinking: the five/four measure. , 1998, Journal of studies on alcohol.
[242] K. Bush,et al. Screening for problem drinking : Comparison of CAGE and AUDIT. , 1998, Journal of general internal medicine.
[243] R. Hultcrantz,et al. Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease. , 1995, Scandinavian journal of gastroenterology.
[244] American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers. , 1995, Gastroenterology.
[245] C. Naylor. The rational clinical examination. Physical examination of the liver. , 1994, JAMA.
[246] B. Grant,et al. Prevalence of DSM-IV Alcohol Abuse and Dependence , 1994, Alcohol health and research world.
[247] P. Hall. Pathological spectrum of alcoholic liver disease. , 1994, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.
[248] P. Chou,et al. Prevalence of DSM-IV Alcohol Abuse and Dependence: United States, 1992. , 1994 .
[249] M. Zillikens,et al. Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls. , 1993, Journal of hepatology.
[250] T. Blaschke,et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. , 1992, Gastroenterology.
[251] F. Grémy,et al. [Corticoid therapy in the treatment of acute alcoholic hepatitis. Results of a meta-analysis]. , 1991, Gastroenterologie clinique et biologique.
[252] J. Levine,et al. The relative value of consultation, questionnaires and laboratory investigation in the identification of excessive alcohol consumption. , 1990, Alcohol and alcoholism.
[253] P. Gartside,et al. Prognostic significance of cholestatic alcoholic hepatitis. VA Cooperative Study Group #119. , 1990, Digestive diseases and sciences.
[254] A. Nanji,et al. Serum aspartate aminotransferase to alanine aminotransferase ratio in human and experimental alcoholic liver disease: relationship to histologic changes. , 1989, Enzyme.
[255] Roger Williams,et al. Factors determining cirrhosis in alcoholic liver disease. , 1988, Molecular aspects of medicine.
[256] A. Medline,et al. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. , 1987, Gastroenterology.
[257] J. Kaprio,et al. Social and genetic influences on drinking patterns of adult men: a study of 5638 Finnish twin brothers. , 1987, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.
[258] A. Chlumská,et al. [Alcoholic hepatitis]. , 1987, Casopis lekaru ceskych.
[259] J. Caballería,et al. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. , 1986, Journal of hepatology.
[260] T. Peters,et al. Liver volume measurement by ultrasonography in normal subjects and alcoholic patients. , 1986, Journal of hepatology.
[261] Roger Williams,et al. Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis. , 1985, Journal of hepatology.
[262] E. Mezey. Commentary on the hypermetabolic state and the role of oxygen in alcohol-induced liver injury. , 1984, Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.
[263] R. Peters,et al. Alcoholic foamy degeneration--a pattern of acute alcoholic injury of the liver. , 1983, Gastroenterology.
[264] J. Henderson,et al. Enteral hyperalimentation in undernourished patients with cirrhosis and ascites. , 1982, The American journal of clinical nutrition.
[265] P. Scheuer,et al. The morphology of alcoholic liver disease. , 1982, British medical bulletin.
[266] S. Borowsky,et al. Continued heavy drinking and survival in alcoholic cirrhotics. , 1981, Gastroenterology.
[267] Alcoholic liver disease: morphological manifestations. Review by an international group. , 1981, Lancet.
[268] M. Omata,et al. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. , 1980, Gastroenterology.
[269] J. Galambos. Alcoholic hepatitis: its therapy and prognosis. , 1972, Progress in liver diseases.
[270] C. M. Leevy. Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. , 1962, Medicine.